Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1
Aggregation of α‐synuclein (αS) is involved in the pathogenesis of Parkinson's disease (PD) and a variety of related neurodegenerative disorders. The physiological function of αS is largely unknown. We demonstrate with in vitro vesicle fusion experiments that αS has an inhibitory function on me...
Saved in:
Published in | The EMBO journal Vol. 29; no. 20; pp. 3571 - 3589 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
20.10.2010
Nature Publishing Group UK Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aggregation of α‐synuclein (αS) is involved in the pathogenesis of Parkinson's disease (PD) and a variety of related neurodegenerative disorders. The physiological function of αS is largely unknown. We demonstrate with
in vitro
vesicle fusion experiments that αS has an inhibitory function on membrane fusion. Upon increased expression in cultured cells and in
Caenorhabditis elegans
, αS binds to mitochondria and leads to mitochondrial fragmentation. In
C. elegans
age‐dependent fragmentation of mitochondria is enhanced and shifted to an earlier time point upon expression of exogenous αS. In contrast, siRNA‐mediated downregulation of αS results in elongated mitochondria in cell culture. αS can act independently of mitochondrial fusion and fission proteins in shifting the dynamic morphologic equilibrium of mitochondria towards reduced fusion. Upon cellular fusion, αS prevents fusion of differently labelled mitochondrial populations. Thus, αS inhibits fusion due to its unique membrane interaction. Finally, mitochondrial fragmentation induced by expression of αS is rescued by coexpression of PINK1, parkin or DJ‐1 but not the PD‐associated mutations PINK1 G309D and parkin Δ1–79 or by DJ‐1 C106A.
This study demonstrates that α‐synuclein, which is implicated in the pathogenesis of Parkinson's disease, regulates mitochondrial dynamics by direct inhibition of membrane fusion. |
---|---|
Bibliography: | ark:/67375/WNG-PWSL5PN7-J istex:A4AD40522E196390A9D0C5681138425AFA0BDED3 ArticleID:EMBJ2010223 Supplementary DataReview Process File ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 These authors contributed equally to this work |
ISSN: | 0261-4189 1460-2075 1460-2075 |
DOI: | 10.1038/emboj.2010.223 |